EPR - the future of bio/pharmaceutical analysis online summit 2025 logo

The Future of

Bio/Pharmaceutical Analysis

Agenda

Day 1  |  Day 2

18th June

19th June

Day 2 – Session 1
Presentation
8:00 – 8:30 BST

The Smart Lab Revolution:

Digitalisation and Automation for Enhanced QA/QC Efficiency and Reliability

  • Discussing the benefits of the smart lab revolution and what practical steps are needed to apply the smart quality approach
  • How companies can effectively digitalise, automate, and integrate their quality controls
  • Focus on some practical examples such as application of a high-throughput automated colony-counting system powered by AI for environmental monitoring
Global Product Manager BioMonitoring – Pharma Innovation
Merck Life Science
Head of Microbiology, New Modalities and Parenteral Development
AstraZeneca
Day 2 – Session 2
Presentation
9:00 – 10:00 BST

Continuous Manufacturing:

Transforming Pharmaceutical Production for Efficiency and Agility

  • Tariffs on pharmaceutical products imposed by the US – the impact on global supply chains and investment decisions
Professor-of-the-Practice, Executive-in-Residence, SERC Director
University of Maryland
Day 2 – Session 3
Presentation
10:30 – 11:30 BST

Next-Gen Biologics Characterisation:

Pushing Boundaries

  • Advanced characterisation of antibody-drug conjugates and complex formats using integrated automated sample fractionation, digestion, and MS workflows

Scientific Director
Symphogen
Sponsored by
Lonza logo
Day 2 – Session 4
Presentation
12:00 – 13:00 BST

Endotoxin Control Strategies for New Products

Head of QA GxP Compliance
Kedrion Biopharma, Inc.
SME Testing Services
Lonza Walkersville, Inc.
Sponsored by
Charles River logo
Day 2 – Session 5
Panel
13:30 – 14:00 BST

Proactive Compliance:

Building Adaptive Quality Systems to Navigate Future Regulatory Landscapes

This session covers:

  • An overview of recent developments in the sector and key lessons learnt. Consideration of how these can inform compliance when building quality systems today
  • How to adapt quality systems amid a rapidly changing industry to support future regulatory compliance
  • Practical strategies for ensuring a flexible approach when navigating changes in regulation
Day 2 – Session 6
Talk / Panel
14:30 – 15:00 BST

Sustainable Pharma:

Driving Efficiency, Innovation, and Long-Term Value Creation

Day 2 – Session 7
Case Study
15:30 – 16:00 BST

Nitrites and Nitrosamines in Pharmaceuticals

Understanding their impact and ensuring compliance

Nitrosamines, especially those formed through nitrites, remain a significant concern in pharmaceutical safety. Staying compliant with evolving regulations is crucial.

This session will provide insights on:

  • Regulatory landscape – overview about recent updates
  • Analytical challenges – techniques for accurate detection
  • Role of nitrites – their contribution to nitrosamine formation
  • Case studies – practical insights and real-world examples
Chemistry Research Director
Merieux NutriSciences
Day 2 – Session 8
Talk / Panel
16:30 – 17:00 BST

Harnessing IoT and Data Analytics for Proactive Contamination Control